News
Biotech cools off in August as capital markets weaken September 01, 2010 | Press Release
Biotech gets hot in July August 02, 2010 | Press Release
Shawn Cross appointed CEO of Burrill Merchant Banking Group July 28, 2010 | Press Release
See all NewsInternational

Michael Keyoung, MD, PhD
Managing Director, Burrill Pan-AsiaKorea, Greater China
Dr. Keyoung has more than 15 years of healthcare and life science experience through his role as scientist, surgeon, consultant and investor. At Burrill & Company, Dr. Keyoung manages Burrill’s Pan-Asia/Korea Private Equity Fund, oversees Burrill’s US and European public portfolio companies and leads our Pan-Asia transaction business as well as our global arbitrage efforts across multiple countries inDr. Keyoung currently serves as an advisory board member to Korea Evaluation Institute of Industrial Technology (KEIT) under the auspice of Ministry of Knowledge Economy of Korean Government. KEIT is a government-run agency that manages Korean national R&D programs and implements government innovation policies with a current budget of $10 billion. Dr. Keyoung has served on the Board of Overseers at the Cornell University-Weill Medical College in
